I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 9 studies | 18% ± 3% | |
| CD4-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 29% ± 10% | |
| ciliated cell | 5 studies | 25% ± 4% | |
| classical monocyte | 4 studies | 24% ± 7% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| non-classical monocyte | 4 studies | 28% ± 9% | |
| natural killer cell | 4 studies | 20% ± 3% | |
| endothelial cell | 4 studies | 21% ± 7% | |
| plasmacytoid dendritic cell | 4 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 1% | |
| conventional dendritic cell | 3 studies | 32% ± 14% | |
| hematopoietic precursor cell | 3 studies | 22% ± 3% | |
| plasma cell | 3 studies | 28% ± 13% | |
| astrocyte | 3 studies | 19% ± 2% | |
| glutamatergic neuron | 3 studies | 39% ± 16% | |
| CD8-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| dendritic cell | 3 studies | 34% ± 9% |
